Clin Asst Prof Soh Shui Boon

Dr Soh Shui Boon is a Senior Consultant with the Department of Endocrinology at Changi General Hospital (CGH).

Dr Soh graduated from Faculty of Medicine obtained her MBBS from, National University of Singapore (NUS) in 2002 and became a member of the Royal College of Physicians of the United Kingdom in 2007. She subsequently completed postgraduate specialty training in endocrinology in Singapore and went on to do did a one-year sabbatical in The Alfred Hospital, Melbourne from 2012 to 2013 to pursue her interest in thyroid diseases. She completed her Masters of Medical Education at University of Dundee in 2026 with distinction.

Dr Soh is also a senior clinical lecturer for Yong Loo Lin School of Medicine and has been associate program director of Singhealth Advanced Internal Medicine Residency Program since the start of the program in 2013. She has won several SingHealth Residency Outstanding Faculty Awards over the years. 

Dr Soh has a keen interest in medical education, and plays an active role in both undergraduate and postgraduate medical education.

• MBBS (Singapore)
• MRCP (United Kingdom)
• Specialist Accreditation in Endocrinology (Singapore)
• Fellowship in Thyroid Diseases (The Alfred Hospital, Melbourne, Australia)
  

• Senior Clinical Lecturer, NUS Yong Loo Lin School of Medicine
• Associate Program Director, SingHealth Advanced Internal Medicine Residency Program
• Core Faculty Member, SingHealth Endocrinology Senior Residency Program
• Physician Faculty Member, SingHealth PGY1 Residency Program
• Physician Faculty Member and Mentor, SingHealth Internal Medicine Residency Program

• SingHealth Residency Program Outstanding Faculty Award (2017)
• Eastern Health Alliance Caring Award – Silver (2017)

• Effects of 4-month therapy of levothyroxine on non-alcoholic fatty liver disease (NAFLD) and diabetes control in diabetic male patients (Site PI; completed)
• A 24-week multicentre, randomized, double-blinded, placebo-controlled, parallel-group, phase 3 trial to evaluate the efficacy and safety of Dapagliflozin added to the therapy of Asian subjects with type 2 diabetes who have inadequate glycemic control on insulin (Site Co-I; completed)
• Prospective diabetes registry of patients with type 2 diabetes mellitus on SGLT2 inhibitor therapy in Singapore (Site Co-I; ongoing) • EDEN study - ELO water in diabetes care for enhancement of blood glucose control (Site Co-I; ongoing)
• PACES PA study - Prospective study assessing blood pressure, cardiovascular, endothelial and other outcomes post surgical and medical treatment in patients with primary aldosteronism (Co-I; ongoing)

• Classification and Laboratory Diagnosis of Diabetes Mellitus Shui-Boon Soh, Duncan J Topliss, 2014, Endocrinology and Diabetes – a Problem-Oriented Approach, Springer (NY). 2014(1): 347-359
• Novel Use of Rituximab in a case of Riedel’s Thyroiditis refractory to Glucocorticoids and Tamoxifen Shui-Boon Soh, Alan Pham, Robyn E O’Hehir, Martin Cherk, Duncan J Topliss J Clin Endo Metab. Sept 2013; 98(9): 3543-49
• Use and Misuse of Thyroid Hormone Duncan J Topliss, Shui-Boon Soh Singapore Medical Journal. Jul 2013; 54(7): 406-10
• Thyroid dysfunction in pregnancy: optimising obstetric outcomes Shui-Boon Soh, Duncan J Topliss Endocrinology Today. Apr 2013; 2(2): 8-16